Exagen Inc. XGN Additional Paid-In Capital
Additional Paid-In Capital at other companies
Other financials
Where this comes from
Reported directly by Exagen Inc. in its filing.
Tagged under the XBRL concept us-gaap:AdditionalPaidInCapital.
The official record: Exagen Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Exagen Inc.'s additional paid-in capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Exagen Inc.'s additional paid-in capital?
- Exagen Inc. (XGN) reported additional paid-in capital of $332.66M in Q1 2026.
- How has Exagen Inc.'s additional paid-in capital changed year-over-year?
- Exagen Inc.'s additional paid-in capital increased by 9.3% year-over-year, from $304.47M to $332.66M.
- What is the long-term trend for Exagen Inc.'s additional paid-in capital?
- Over 5 years (2020 to 2025), Exagen Inc.'s additional paid-in capital has grown at a 8.3% compound annual growth rate (CAGR), from $223.12M to $331.71M.
- What does additional paid-in capital mean?
- Capital received from shareholders in excess of par value — the premium investors paid over the nominal value of shares at issuance, plus stock-based compensation effects.